Baird reiterated an Outperform rating on Celgene (NASDAQ: CELG) and raised its price target to $92.00 (from $78.00).

"With ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE